When does amphetamine-induced psychosis become schizophrenia?

American Journal of Psychiatry

Volumn 153, Issue 6, 1996, Pages 812-815

  Flaum, Michael ^a   Schultz, Susan K ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; AMPHETAMINE DERIVATIVE; BENZATROPINE; CANNABIS; COCAINE; DISULFIRAM; HALOPERIDOL; LYSERGIDE; MESCALINE; PROPRANOLOL; PSYCHEDELIC AGENT;

ADULT; ALCOHOLISM; CASE REPORT; CLINICAL FEATURE; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; DRUG ABUSE; DRUG BLOOD LEVEL; EXTRAPYRAMIDAL SYMPTOM; HUMAN; MALE; MEDICAL RECORD; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; SCHIZOPHRENIA; SUBSTANCE ABUSE;

EID: 0030001477     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.153.6.812     Document Type: Conference Paper

References (21)

1. Walker EF, Grimes KE, Davis DM, Smith AJ: Childhood precursors of schizophrenia: facial expressions of emotion. Am J Psychiatry 1993; 150:1654-1660
2. Coryell WH, Kelly MW, Perry PJ, Miller DD: Haloperidol plasma levels and acute clinical change in schizophrenia. J Clin Psychopharmacol 1990; 10:397-402
3. Connell PH: Amphetamine Psychosis: Maudsley Monograph, vol 5. London, Chapman & Hall, 1958
4. Bell DS: The experimental reproduction of amphetamine psychosis. Arch Gen Psychiatry 1973; 29:35-40
5. Snyder SH, Banerjee SP, Yamamura HI, Greenberg D: Drugs, neurotransmitters, and schizophrenia. Science 1974; 184:1243-1253
6. Robinson TK, Becker JB: Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 1986; 11:157-198
7. Kalivas PW, Stewart J: Dopamine transmission in the initiation and expression of drug-and stress-induced sensitization of motor activity. Brain Res Brain Res Rev 1991; 16:223-244
8. Antelman SM: Stressor-induced sensitization to subsequent stress: implications for the development and treatment of clinical disorders, in Sensitization in the Nervous System: Advances in Physiology, vol 1. Edited by Kalivas PVC, Barnes CD, Caldwell, NJ, Telford Press, 1988, pp 227-256
9. Kalivas PW, Barnes CD (eds): Sensitization in the Nervous System: Advances in Physiology, vol 1. Caldwell, NJ, Telford Press, 1988
10. Downs AW, Eddy NB: The effect of repeated doses of cocaine on the rat. J Pharmacol Exp Ther 1932; 46:199-202
11. Angrist BM, Sudilovsky A: Central nervous system stimulants: historical aspects and clinical effects, in Handbook of Psychopharmacology: Stimulants, vol 11. Edited by Iversen LL, Iversen SD, Snyder SH. New York, Plenum, 1978, pp 175-199
12. Kalivas PW: Neural substrate of sensitization to psychostimulants. Clin Neuropharmacol 1992; 15(suppl 1, part A):648A-649A
13. Kalivas PW: Interactions between dopamine and excitatory amino acids in behavioral sensitization to psychostimulants. Drug Alcohol Depend 1995; 37:95-100
14. Antelman SM: Interchangeability of stress and amphetamine in sensitization. Science 1980; 207:329-331
15. Lieberman JA, Kinon BJ, Loebel AD: Dopaminergic mechanisms in idiopathic and drug-induced psychoses. Schizophr Bull 1990; 16: 97-110
16. Sato M, Numachi Y, Hamamura T: Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophr Bull 1992; 18:15-122
17. Lieberman JA, Alvir J, Geisler S, Ramos-Lorenzi J, Woerner M, Novacenko H, Cooper T, Kane JM: Merhylphenidate response, psychopathology and tardive dyskinesia as predictors of relapse in schizophrenia. Neuropsychopharmacology 1994; 11:107-118
18. Levy DL, Smith M, Robinson D, Jody D, Lerner G, Alvir J, Geisler SH, Szymanski SR, Gonzalez A, Mayerhoff DI, Lieberman JA, Mendell NR: Methylphenidatc increases thought disorder in recent onset schizophrenics, but not in normal controls. Biol Psychiatry 1993; 34:507-514
19. Sharma RP, Javaid JI, Pandey GN, Janicak PG, Davis JM: Behavioral and biochemical effects of methylphenidate in schizophrenic and nonschizophrenic patients. Biol Psychiatry 1991; 30:459-466
20. Lieberman J, Jody D, Geisler S, Alvir J, Loebel A, Szymanski S, Woerner M, Borenstein M: Time course and biologic correlates of treatment response in first-episode schizophrenia. Arch Gen Psychiatry 1993; 50:369-376
21. Tatetsu S, Goto A, Fujiwara T: [The Methamphetamine Psychosis]. Tokyo, Igakushoin, 1956 (Japanese)